Changes
On June 30, 2022, 09:25:56 (SAST),
-
Updated description of Africa/global vaccination rollouts from
<p>This folder has three files: - A table of the types of Covid-19 vaccines and their manufacturers which are fully approved or approved only for emergency use - A table of countries that have approved the Covid-19 vaccines - A table of doses delivered to countries </p> *This data was last updated on 30 June 2022.*
to<p>This folder has three files: </p> - A table of the types of Covid-19 vaccines and their manufacturers which are fully approved or approved only for emergency use - A table of countries that have approved the Covid-19 vaccines - A table of doses delivered to countries <br />*This data was last updated on 30 June 2022.*. <br />*For the full methodology see this file [here](https://docs.google.com/document/d/e/2PACX-1vRuwJFtDRnsyFwnmvn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)
f | 1 | { | f | 1 | { |
2 | "author": "Gemma Ritchie", | 2 | "author": "Gemma Ritchie", | ||
3 | "author_email": "[email protected]", | 3 | "author_email": "[email protected]", | ||
4 | "creator_user_id": "251278fa-64c7-42e2-a21a-5bb96c670399", | 4 | "creator_user_id": "251278fa-64c7-42e2-a21a-5bb96c670399", | ||
5 | "extras": [], | 5 | "extras": [], | ||
6 | "groups": [], | 6 | "groups": [], | ||
7 | "id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 7 | "id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
8 | "isopen": true, | 8 | "isopen": true, | ||
9 | "license_id": "cc-by", | 9 | "license_id": "cc-by", | ||
10 | "license_title": "Creative Commons Attribution", | 10 | "license_title": "Creative Commons Attribution", | ||
11 | "license_url": "http://www.opendefinition.org/licenses/cc-by", | 11 | "license_url": "http://www.opendefinition.org/licenses/cc-by", | ||
12 | "maintainer": "Gemma Ritchie", | 12 | "maintainer": "Gemma Ritchie", | ||
13 | "maintainer_email": "[email protected]", | 13 | "maintainer_email": "[email protected]", | ||
14 | "metadata_created": "2022-06-30T06:48:12.490391", | 14 | "metadata_created": "2022-06-30T06:48:12.490391", | ||
n | 15 | "metadata_modified": "2022-06-30T07:24:45.046835", | n | 15 | "metadata_modified": "2022-06-30T07:25:56.796619", |
16 | "name": "africa-global-vaccination-rollouts", | 16 | "name": "africa-global-vaccination-rollouts", | ||
n | 17 | "notes": "<p>This folder has three files:\r\n- A table of the types | n | 17 | "notes": "<p>This folder has three files: </p>\r\n- A table of the |
18 | of Covid-19 vaccines and their manufacturers which are fully approved | 18 | types of Covid-19 vaccines and their manufacturers which are fully | ||
19 | or approved only for emergency use\r\n- A table of countries that have | 19 | approved or approved only for emergency use\r\n- A table of countries | ||
20 | approved the Covid-19 vaccines\r\n- A table of doses delivered to | 20 | that have approved the Covid-19 vaccines\r\n- A table of doses | ||
21 | countries\r\n</p>\r\n*This data was last updated on 30 June 2022.*", | 21 | delivered to countries\r\n\r\n<br />*This data was last updated on 30 | ||
22 | June 2022.*. \r\n<br />*For the full methodology see this file | ||||
23 | vn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)", | ||||
22 | "num_resources": 3, | 24 | "num_resources": 3, | ||
23 | "num_tags": 5, | 25 | "num_tags": 5, | ||
24 | "organization": { | 26 | "organization": { | ||
25 | "approval_status": "approved", | 27 | "approval_status": "approved", | ||
26 | "created": "2022-06-29T10:06:22.005628", | 28 | "created": "2022-06-29T10:06:22.005628", | ||
27 | "description": "Media Hack Collective collect, analyse, and | 29 | "description": "Media Hack Collective collect, analyse, and | ||
28 | visualise data to tell engaging and effective stories. Media Hack | 30 | visualise data to tell engaging and effective stories. Media Hack | ||
29 | Collective are a partner organisation in the Africa Data Hub. Their | 31 | Collective are a partner organisation in the Africa Data Hub. Their | ||
30 | website can be found [here](https://mediahack.co.za/)", | 32 | website can be found [here](https://mediahack.co.za/)", | ||
31 | "id": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | 33 | "id": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | ||
32 | "image_url": "https://mediahack.co.za/_images/logo.png", | 34 | "image_url": "https://mediahack.co.za/_images/logo.png", | ||
33 | "is_organization": true, | 35 | "is_organization": true, | ||
34 | "name": "media-hack-collective", | 36 | "name": "media-hack-collective", | ||
35 | "revision_id": "f7699549-076b-4559-b7e5-039726d1ff76", | 37 | "revision_id": "f7699549-076b-4559-b7e5-039726d1ff76", | ||
36 | "state": "active", | 38 | "state": "active", | ||
37 | "title": "Media Hack Collective", | 39 | "title": "Media Hack Collective", | ||
38 | "type": "organization" | 40 | "type": "organization" | ||
39 | }, | 41 | }, | ||
40 | "owner_org": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | 42 | "owner_org": "8534c5fe-53e5-4ced-a6ae-efd881d571ab", | ||
41 | "private": false, | 43 | "private": false, | ||
42 | "relationships_as_object": [], | 44 | "relationships_as_object": [], | ||
43 | "relationships_as_subject": [], | 45 | "relationships_as_subject": [], | ||
44 | "resources": [ | 46 | "resources": [ | ||
45 | { | 47 | { | ||
46 | "cache_last_updated": null, | 48 | "cache_last_updated": null, | ||
47 | "cache_url": null, | 49 | "cache_url": null, | ||
48 | "created": "2022-06-30T07:07:52.749707", | 50 | "created": "2022-06-30T07:07:52.749707", | ||
49 | "datastore_active": false, | 51 | "datastore_active": false, | ||
50 | "description": "<p>This dataset contains descriptive information | 52 | "description": "<p>This dataset contains descriptive information | ||
51 | about vaccines that are in use in countries around the world or have | 53 | about vaccines that are in use in countries around the world or have | ||
52 | been approved for use (emergency, limited, or full approval), along | 54 | been approved for use (emergency, limited, or full approval), along | ||
53 | with information on who manufacturers the vaccine, type of vaccine, | 55 | with information on who manufacturers the vaccine, type of vaccine, | ||
54 | number of doses required etc. New vaccines will be added when they are | 56 | number of doses required etc. New vaccines will be added when they are | ||
55 | either approved by a country, or a country starts to vaccinate with | 57 | either approved by a country, or a country starts to vaccinate with | ||
56 | them. </p> \r\n<br /> *Data as of 30 June 2022*. \r\n\r\n<br | 58 | them. </p> \r\n<br /> *Data as of 30 June 2022*. \r\n\r\n<br | ||
57 | />##Description of variables\r\n<br />**ID:**ID number. \r\n\r\n<br /> | 59 | />##Description of variables\r\n<br />**ID:**ID number. \r\n\r\n<br /> | ||
58 | **Vaccine_platform_acronymn:**Acronym for platform used to carry the | 60 | **Vaccine_platform_acronymn:**Acronym for platform used to carry the | ||
59 | vaccine. \r\n\r\n<br />**Vaccine_platform_description:** Description | 61 | vaccine. \r\n\r\n<br />**Vaccine_platform_description:** Description | ||
60 | of platform used to carry the vaccine. \r\n\r\n<br | 62 | of platform used to carry the vaccine. \r\n\r\n<br | ||
61 | />**Number_of_doses:** Number of doses of vaccine needed to be fully | 63 | />**Number_of_doses:** Number of doses of vaccine needed to be fully | ||
62 | vaccinated. \r\n\r\n<br />**Dosing_schedule** Days when vaccines | 64 | vaccinated. \r\n\r\n<br />**Dosing_schedule** Days when vaccines | ||
63 | should be delivered. \r\n\r\n<br />**Route_of_administration:** How is | 65 | should be delivered. \r\n\r\n<br />**Route_of_administration:** How is | ||
64 | vaccine administered. \r\n\r\n<br />**Type_of_vaccine:** Description | 66 | vaccine administered. \r\n\r\n<br />**Type_of_vaccine:** Description | ||
65 | of the type of vaccine. \r\n\r\n<br />**Names:** The name of the | 67 | of the type of vaccine. \r\n\r\n<br />**Names:** The name of the | ||
66 | vaccine, this is sometimes more like a product code than a name eg | 68 | vaccine, this is sometimes more like a product code than a name eg | ||
67 | BBIBP-CorV, or Ad26.COV2.S. Some vaccines appear to have more than one | 69 | BBIBP-CorV, or Ad26.COV2.S. Some vaccines appear to have more than one | ||
68 | name. \r\n\r\n<br />**Common_name:** The most commonly used name of a | 70 | name. \r\n\r\n<br />**Common_name:** The most commonly used name of a | ||
69 | vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | 71 | vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | ||
70 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | 72 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | ||
71 | \r\n\r\n<br />**storage:** Temperature at which vaccine has to be | 73 | \r\n\r\n<br />**storage:** Temperature at which vaccine has to be | ||
72 | stored. \r\n\r\n<br />**Developers:** Name of company that developed | 74 | stored. \r\n\r\n<br />**Developers:** Name of company that developed | ||
73 | the vaccine. \r\n\r\n<br />**Country_of_origin:** Country or countries | 75 | the vaccine. \r\n\r\n<br />**Country_of_origin:** Country or countries | ||
74 | developer company is based. \r\n\r\n<br />**Phase:** Phase of clinical | 76 | developer company is based. \r\n\r\n<br />**Phase:** Phase of clinical | ||
75 | trial. \r\n\r\n<br />**Covax:** Yes or No variable. Is the vaccine | 77 | trial. \r\n\r\n<br />**Covax:** Yes or No variable. Is the vaccine | ||
76 | part of the Covax initiative? \r\n\r\n<br | 78 | part of the Covax initiative? \r\n\r\n<br | ||
77 | />**WHO_emergency_use_listing:** Description of where the vaccine is | 79 | />**WHO_emergency_use_listing:** Description of where the vaccine is | ||
78 | in the WHO\u2019s emergency listing process. \r\n\r\n<br | 80 | in the WHO\u2019s emergency listing process. \r\n\r\n<br | ||
79 | />**Data_of_who_recommendation:** Date on which WHO emergency use | 81 | />**Data_of_who_recommendation:** Date on which WHO emergency use | ||
80 | listing was approved\r\n \r\n\r\n<br />**efficacy_1:** Percentage. | 82 | listing was approved\r\n \r\n\r\n<br />**efficacy_1:** Percentage. | ||
81 | What is the vaccine\u2019s efficacy on \u201cwild\u201d SARS-Cov-2 | 83 | What is the vaccine\u2019s efficacy on \u201cwild\u201d SARS-Cov-2 | ||
82 | virus from Phase 3 or 4 clinical trials? \r\n\r\n<br /> | 84 | virus from Phase 3 or 4 clinical trials? \r\n\r\n<br /> | ||
83 | **efficacy_RSA:** Percentage. What is the efficacy of the virus when | 85 | **efficacy_RSA:** Percentage. What is the efficacy of the virus when | ||
84 | tested against the B.1.315 variant, which is dominant in South Africa? | 86 | tested against the B.1.315 variant, which is dominant in South Africa? | ||
85 | \r\n\r\n<br />**date_of_test_results_1:** Date the efficacy_1 results | 87 | \r\n\r\n<br />**date_of_test_results_1:** Date the efficacy_1 results | ||
86 | were published. \r\n\r\n<br />**Results_published:** No means results | 88 | were published. \r\n\r\n<br />**Results_published:** No means results | ||
87 | have not been published in peer-reviewed journal. Name of journal if | 89 | have not been published in peer-reviewed journal. Name of journal if | ||
88 | results have been published. \r\n\r\n<br | 90 | results have been published. \r\n\r\n<br | ||
89 | />**date_results-published:**Date when results were published in | 91 | />**date_results-published:**Date when results were published in | ||
90 | peer-reviewed journal\r\n\r\n<br /> | 92 | peer-reviewed journal\r\n\r\n<br /> | ||
91 | j6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n\r\n\r\n", | 93 | j6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n\r\n\r\n", | ||
92 | "format": "", | 94 | "format": "", | ||
93 | "hash": "", | 95 | "hash": "", | ||
94 | "id": "f2f33f2f-2be1-4f65-9751-b2cbbd5446a4", | 96 | "id": "f2f33f2f-2be1-4f65-9751-b2cbbd5446a4", | ||
95 | "last_modified": null, | 97 | "last_modified": null, | ||
96 | "mimetype": null, | 98 | "mimetype": null, | ||
97 | "mimetype_inner": null, | 99 | "mimetype_inner": null, | ||
98 | "name": "Vaccine types", | 100 | "name": "Vaccine types", | ||
99 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 101 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
100 | "position": 0, | 102 | "position": 0, | ||
101 | "resource_type": null, | 103 | "resource_type": null, | ||
102 | "revision_id": "7cee2933-059c-481d-b499-9cf8dba388a4", | 104 | "revision_id": "7cee2933-059c-481d-b499-9cf8dba388a4", | ||
103 | "size": null, | 105 | "size": null, | ||
104 | "state": "active", | 106 | "state": "active", | ||
105 | "url": | 107 | "url": | ||
106 | nLY7XDGB5PAr1oErpwp1PyG_bb9nEFTPql/pubhtml?gid=883047759&single=true", | 108 | nLY7XDGB5PAr1oErpwp1PyG_bb9nEFTPql/pubhtml?gid=883047759&single=true", | ||
107 | "url_type": null | 109 | "url_type": null | ||
108 | }, | 110 | }, | ||
109 | { | 111 | { | ||
110 | "cache_last_updated": null, | 112 | "cache_last_updated": null, | ||
111 | "cache_url": null, | 113 | "cache_url": null, | ||
112 | "created": "2022-06-30T07:15:41.065396", | 114 | "created": "2022-06-30T07:15:41.065396", | ||
113 | "datastore_active": false, | 115 | "datastore_active": false, | ||
114 | "description": "<p> This dataset contains a list of countries | 116 | "description": "<p> This dataset contains a list of countries | ||
115 | and the types of Covid vaccines they are using. It includes when | 117 | and the types of Covid vaccines they are using. It includes when | ||
116 | vaccination started for each vaccine type, where the vaccine is fully | 118 | vaccination started for each vaccine type, where the vaccine is fully | ||
117 | approved for use in that country, the date of approval, where | 119 | approved for use in that country, the date of approval, where | ||
118 | available, and whether it is supplied by Covax. </p>\r\n<p>**Source:** | 120 | available, and whether it is supplied by Covax. </p>\r\n<p>**Source:** | ||
119 | Multiple sources. See | 121 | Multiple sources. See | ||
120 | nmvn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub) | 122 | nmvn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub) | ||
121 | section. Also sources are in the dataset.</p>\r\n\r\n<br />*This data | 123 | section. Also sources are in the dataset.</p>\r\n\r\n<br />*This data | ||
122 | was last updated on 30 June 2022.* \r\n\r\n<br /> Description of | 124 | was last updated on 30 June 2022.* \r\n\r\n<br /> Description of | ||
123 | variables. \r\n================================== \r\n<br | 125 | variables. \r\n================================== \r\n<br | ||
124 | />**iso_code:** 3-letter ISO country code. \r\n\r\n<br | 126 | />**iso_code:** 3-letter ISO country code. \r\n\r\n<br | ||
125 | />**continent:** Name of continent. \r\n\r\n<br />**country:** Name of | 127 | />**continent:** Name of continent. \r\n\r\n<br />**country:** Name of | ||
126 | country. \r\n\r\n<br />**common _name:** The most commonly used name | 128 | country. \r\n\r\n<br />**common _name:** The most commonly used name | ||
127 | of a vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | 129 | of a vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | ||
128 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | 130 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | ||
129 | \r\n\r\n<br />**supplier_name:** Name of company that developed the | 131 | \r\n\r\n<br />**supplier_name:** Name of company that developed the | ||
130 | vaccine. Same as develop variable in Sheet 1: Vaccines. \r\n\r\n<br | 132 | vaccine. Same as develop variable in Sheet 1: Vaccines. \r\n\r\n<br | ||
131 | />**authorised_emergency_use:** Yes or blank cell. The table of | 133 | />**authorised_emergency_use:** Yes or blank cell. The table of | ||
132 | vaccines used by countries around the world is triggered by a Yes. | 134 | vaccines used by countries around the world is triggered by a Yes. | ||
133 | \r\n\r\n<br />**date_authorised_emergency_use:** Date when a | 135 | \r\n\r\n<br />**date_authorised_emergency_use:** Date when a | ||
134 | country\u2019s health ministry authorised a vaccine for emergency or | 136 | country\u2019s health ministry authorised a vaccine for emergency or | ||
135 | limited use. \r\n\r\n<br />**vaccination_started:** Yes or blank cell. | 137 | limited use. \r\n\r\n<br />**vaccination_started:** Yes or blank cell. | ||
136 | The table of vaccines used by countries around the world is triggered | 138 | The table of vaccines used by countries around the world is triggered | ||
137 | by a Yes. As is the Africa map vaccine tracker\r\n\r\n<br | 139 | by a Yes. As is the Africa map vaccine tracker\r\n\r\n<br | ||
138 | />**date_vaccination _started:** Date country started to vaccinate | 140 | />**date_vaccination _started:** Date country started to vaccinate | ||
139 | people with a vaccine. \r\n\r\n<br />**approved:** Yes or blank cell. | 141 | people with a vaccine. \r\n\r\n<br />**approved:** Yes or blank cell. | ||
140 | Has a vaccine been fully approved by a country? \r\n\r\n<br | 142 | Has a vaccine been fully approved by a country? \r\n\r\n<br | ||
141 | />**date_approved:** Date country announced full approval for a | 143 | />**date_approved:** Date country announced full approval for a | ||
142 | vaccine. \r\n\r\n<br />**covax_supplied:** Yes or blank cell. Did | 144 | vaccine. \r\n\r\n<br />**covax_supplied:** Yes or blank cell. Did | ||
143 | country receive vaccine through Covax initiative? \r\n\r\n<br | 145 | country receive vaccine through Covax initiative? \r\n\r\n<br | ||
144 | />**authorised_source:** URLs of all the sources for the data in the | 146 | />**authorised_source:** URLs of all the sources for the data in the | ||
145 | authorised_emergency_use, date_athorised_emergency_use, approved and | 147 | authorised_emergency_use, date_athorised_emergency_use, approved and | ||
146 | date_approved variables. List of URLs, separated by semicolons. | 148 | date_approved variables. List of URLs, separated by semicolons. | ||
147 | \r\n\r\n<br />**vaccination_source:** URLs of all the sources for the | 149 | \r\n\r\n<br />**vaccination_source:** URLs of all the sources for the | ||
148 | data in the vaccination_started and date_vaccination_started | 150 | data in the vaccination_started and date_vaccination_started | ||
149 | variables. List of URLs, separated by semicolons. | 151 | variables. List of URLs, separated by semicolons. | ||
150 | uWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n", | 152 | uWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)\r\n", | ||
151 | "format": "", | 153 | "format": "", | ||
152 | "hash": "", | 154 | "hash": "", | ||
153 | "id": "b905738c-ce6a-40d6-b628-482a48364993", | 155 | "id": "b905738c-ce6a-40d6-b628-482a48364993", | ||
154 | "last_modified": null, | 156 | "last_modified": null, | ||
155 | "mimetype": null, | 157 | "mimetype": null, | ||
156 | "mimetype_inner": null, | 158 | "mimetype_inner": null, | ||
157 | "name": "Africa/global vaccination rollouts", | 159 | "name": "Africa/global vaccination rollouts", | ||
158 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 160 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
159 | "position": 1, | 161 | "position": 1, | ||
160 | "resource_type": null, | 162 | "resource_type": null, | ||
161 | "revision_id": "3f1ea78d-a86c-476b-a496-f67e82cc9316", | 163 | "revision_id": "3f1ea78d-a86c-476b-a496-f67e82cc9316", | ||
162 | "size": null, | 164 | "size": null, | ||
163 | "state": "active", | 165 | "state": "active", | ||
164 | "url": | 166 | "url": | ||
165 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=495726462&single=true&output=csv", | 167 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=495726462&single=true&output=csv", | ||
166 | "url_type": null | 168 | "url_type": null | ||
167 | }, | 169 | }, | ||
168 | { | 170 | { | ||
169 | "cache_last_updated": null, | 171 | "cache_last_updated": null, | ||
170 | "cache_url": null, | 172 | "cache_url": null, | ||
171 | "created": "2022-06-30T07:20:31.078417", | 173 | "created": "2022-06-30T07:20:31.078417", | ||
172 | "datastore_active": false, | 174 | "datastore_active": false, | ||
173 | "description": "<p>This dataset lists all countries that have | 175 | "description": "<p>This dataset lists all countries that have | ||
174 | received vaccines from the Covax initiative, through bi-lateral | 176 | received vaccines from the Covax initiative, through bi-lateral | ||
175 | donations, bought from pharmaceutical companies, from the Africa | 177 | donations, bought from pharmaceutical companies, from the Africa | ||
176 | Vaccine Acquisition Trust, the vaccine received, the number of doses | 178 | Vaccine Acquisition Trust, the vaccine received, the number of doses | ||
177 | and the date received. </p>\r\n\r\n<br /> *Last updated on 30 June | 179 | and the date received. </p>\r\n\r\n<br /> *Last updated on 30 June | ||
178 | 2022*. \r\n<br />**iso_code:** 3-letter ISO country code. \r\n\r\n<br | 180 | 2022*. \r\n<br />**iso_code:** 3-letter ISO country code. \r\n\r\n<br | ||
179 | />**continent:** Name of continent. \r\n\r\n<br />**country:** Name of | 181 | />**continent:** Name of continent. \r\n\r\n<br />**country:** Name of | ||
180 | country. \r\n\r\n<br />**common _name:** The most commonly used name | 182 | country. \r\n\r\n<br />**common _name:** The most commonly used name | ||
181 | of a vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | 183 | of a vaccine. eg, BBIBP-CorV is more commonly known as the Sinopharm | ||
182 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | 184 | vaccine and Ad26.COV2.S is the Johnson & Johnson vaccine. | ||
183 | \r\n\r\n<br />**supplier_name:** Name of company that developed the | 185 | \r\n\r\n<br />**supplier_name:** Name of company that developed the | ||
184 | vaccine. \r\n \r\n<br />**doses_received:** Number of doses received | 186 | vaccine. \r\n \r\n<br />**doses_received:** Number of doses received | ||
185 | in a particular shipment. \r\n\r\n<br />**bought_donated:** | 187 | in a particular shipment. \r\n\r\n<br />**bought_donated:** | ||
186 | \u201cBought\u201d means a country bought the vaccines, | 188 | \u201cBought\u201d means a country bought the vaccines, | ||
187 | \u201cDonated\u201d means they were donated, \u201cCovax\u201d means | 189 | \u201cDonated\u201d means they were donated, \u201cCovax\u201d means | ||
188 | they came via Covax, \u201cprivate\u201d when private institutions buy | 190 | they came via Covax, \u201cprivate\u201d when private institutions buy | ||
189 | vaccines; \u201csold\u201d when a country sells vaccines they received | 191 | vaccines; \u201csold\u201d when a country sells vaccines they received | ||
190 | to another country; \u201cdonated-out\u201d is when a country donates | 192 | to another country; \u201cdonated-out\u201d is when a country donates | ||
191 | vaccines to another with no expectation of reciprocity. \r\n\r\n<br | 193 | vaccines to another with no expectation of reciprocity. \r\n\r\n<br | ||
192 | />**donor:** Name of the country or group of countries supplying the | 194 | />**donor:** Name of the country or group of countries supplying the | ||
193 | vaccines received. \r\n\r\n<br />**covax:** Yes or No variable. Is | 195 | vaccines received. \r\n\r\n<br />**covax:** Yes or No variable. Is | ||
194 | the vaccine part of the Covax initiative? \r\n\r\n<br | 196 | the vaccine part of the Covax initiative? \r\n\r\n<br | ||
195 | />**date_received:** Date shipment of vaccines was delivered. | 197 | />**date_received:** Date shipment of vaccines was delivered. | ||
196 | \r\n\r\n<br />**source:** URL link to source of information. | 198 | \r\n\r\n<br />**source:** URL link to source of information. | ||
197 | \r\n\r\n<br />**source_2:** URL link to source of information. | 199 | \r\n\r\n<br />**source_2:** URL link to source of information. | ||
198 | \r\n\r\n<br />**source_3:** URL link to source of | 200 | \r\n\r\n<br />**source_3:** URL link to source of | ||
199 | vn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)", | 201 | vn1vuWilHC6tj6mGptCana7DDJ3e8qP1E-ZpJFQ2EAl24JKQeHGk3Pe2cXhDGA4/pub)", | ||
200 | "format": "", | 202 | "format": "", | ||
201 | "hash": "", | 203 | "hash": "", | ||
202 | "id": "09545054-d15d-45a0-b49a-3ab37a934c78", | 204 | "id": "09545054-d15d-45a0-b49a-3ab37a934c78", | ||
203 | "last_modified": null, | 205 | "last_modified": null, | ||
204 | "mimetype": null, | 206 | "mimetype": null, | ||
205 | "mimetype_inner": null, | 207 | "mimetype_inner": null, | ||
206 | "name": "Global vaccine deliveries", | 208 | "name": "Global vaccine deliveries", | ||
207 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | 209 | "package_id": "704a0635-2d2b-4cae-bc9c-59721ade20a4", | ||
208 | "position": 2, | 210 | "position": 2, | ||
209 | "resource_type": null, | 211 | "resource_type": null, | ||
210 | "revision_id": "48398d2e-7c15-415d-a4ec-4a95277137cb", | 212 | "revision_id": "48398d2e-7c15-415d-a4ec-4a95277137cb", | ||
211 | "size": null, | 213 | "size": null, | ||
212 | "state": "active", | 214 | "state": "active", | ||
213 | "url": | 215 | "url": | ||
214 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=789081741&single=true&output=csv", | 216 | B5PAr1oErpwp1PyG_bb9nEFTPql/pub?gid=789081741&single=true&output=csv", | ||
215 | "url_type": null | 217 | "url_type": null | ||
216 | } | 218 | } | ||
217 | ], | 219 | ], | ||
t | 218 | "revision_id": "48398d2e-7c15-415d-a4ec-4a95277137cb", | t | 220 | "revision_id": "e26e0596-f96a-4030-9b7a-4f97e75bfc74", |
219 | "state": "active", | 221 | "state": "active", | ||
220 | "tags": [ | 222 | "tags": [ | ||
221 | { | 223 | { | ||
222 | "display_name": "Africa", | 224 | "display_name": "Africa", | ||
223 | "id": "011a15dd-a5a0-470e-bb50-86536530d821", | 225 | "id": "011a15dd-a5a0-470e-bb50-86536530d821", | ||
224 | "name": "Africa", | 226 | "name": "Africa", | ||
225 | "state": "active", | 227 | "state": "active", | ||
226 | "vocabulary_id": null | 228 | "vocabulary_id": null | ||
227 | }, | 229 | }, | ||
228 | { | 230 | { | ||
229 | "display_name": "Covax", | 231 | "display_name": "Covax", | ||
230 | "id": "abf146ec-dc99-4a7c-979c-052791e475c8", | 232 | "id": "abf146ec-dc99-4a7c-979c-052791e475c8", | ||
231 | "name": "Covax", | 233 | "name": "Covax", | ||
232 | "state": "active", | 234 | "state": "active", | ||
233 | "vocabulary_id": null | 235 | "vocabulary_id": null | ||
234 | }, | 236 | }, | ||
235 | { | 237 | { | ||
236 | "display_name": "Covid-19", | 238 | "display_name": "Covid-19", | ||
237 | "id": "e1e63920-b518-40c0-89dc-f13aa4c02737", | 239 | "id": "e1e63920-b518-40c0-89dc-f13aa4c02737", | ||
238 | "name": "Covid-19", | 240 | "name": "Covid-19", | ||
239 | "state": "active", | 241 | "state": "active", | ||
240 | "vocabulary_id": null | 242 | "vocabulary_id": null | ||
241 | }, | 243 | }, | ||
242 | { | 244 | { | ||
243 | "display_name": "Covid-19 vaccines", | 245 | "display_name": "Covid-19 vaccines", | ||
244 | "id": "5c7bebc8-269d-495a-9148-8b9619a3c4d9", | 246 | "id": "5c7bebc8-269d-495a-9148-8b9619a3c4d9", | ||
245 | "name": "Covid-19 vaccines", | 247 | "name": "Covid-19 vaccines", | ||
246 | "state": "active", | 248 | "state": "active", | ||
247 | "vocabulary_id": null | 249 | "vocabulary_id": null | ||
248 | }, | 250 | }, | ||
249 | { | 251 | { | ||
250 | "display_name": "vaccines", | 252 | "display_name": "vaccines", | ||
251 | "id": "223adf5d-c358-41a8-bcb7-d0c4008bf122", | 253 | "id": "223adf5d-c358-41a8-bcb7-d0c4008bf122", | ||
252 | "name": "vaccines", | 254 | "name": "vaccines", | ||
253 | "state": "active", | 255 | "state": "active", | ||
254 | "vocabulary_id": null | 256 | "vocabulary_id": null | ||
255 | } | 257 | } | ||
256 | ], | 258 | ], | ||
257 | "title": "Africa/global vaccination rollouts", | 259 | "title": "Africa/global vaccination rollouts", | ||
258 | "type": "dataset", | 260 | "type": "dataset", | ||
259 | "url": "Multiple sources. See Methodology section", | 261 | "url": "Multiple sources. See Methodology section", | ||
260 | "version": "" | 262 | "version": "" | ||
261 | } | 263 | } |